These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36198179)

  • 1. Trial of Intravenous Immune Globulin in Dermatomyositis.
    Aggarwal R; Charles-Schoeman C; Schessl J; Bata-Csörgő Z; Dimachkie MM; Griger Z; Moiseev S; Oddis C; Schiopu E; Vencovský J; Beckmann I; Clodi E; Bugrova O; Dankó K; Ernste F; Goyal NA; Heuer M; Hudson M; Hussain YM; Karam C; Magnolo N; Nelson R; Pozur N; Prystupa L; Sárdy M; Valenzuela G; van der Kooi AJ; Vu T; Worm M; Levine T;
    N Engl J Med; 2022 Oct; 387(14):1264-1278. PubMed ID: 36198179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis ("ProDERM Study").
    Aggarwal R; Charles-Schoeman C; Schessl J; Dimachkie MM; Beckmann I; Levine T
    Medicine (Baltimore); 2021 Jan; 100(1):e23677. PubMed ID: 33429735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study.
    Aggarwal R; Schessl J; Charles-Schoeman C; Bata-Csörgő Z; Dimachkie MM; Griger Z; Moiseev S; Oddis CV; Schiopu E; Vencovský J; Beckmann I; Clodi E; Levine T;
    Arthritis Res Ther; 2024 Jan; 26(1):27. PubMed ID: 38233885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
    Loncharich MF; Anderson CW
    ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of intravenous immunoglobulins (IVIg) in improving skin symptoms in patients with dermatomyositis: a post-hoc analysis of the ProDERM study.
    Werth VP; Aggarwal R; Charles-Schoeman C; Schessl J; Levine T; Kopasz N; Worm M; Bata-Csörgő Z
    EClinicalMedicine; 2023 Oct; 64():102234. PubMed ID: 37799613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.
    Dalakas MC; Illa I; Dambrosia JM; Soueidan SA; Stein DP; Otero C; Dinsmore ST; McCrosky S
    N Engl J Med; 1993 Dec; 329(27):1993-2000. PubMed ID: 8247075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Dose Intravenous Immunoglobulin Treatment for Long-Standing Complex Regional Pain Syndrome: A Randomized Trial.
    Goebel A; Bisla J; Carganillo R; Frank B; Gupta R; Kelly J; McCabe C; Murphy C; Padfield N; Phillips C; Sanders M; Serpell M; Shenker N; Shoukrey K; Wyatt L; Ambler G
    Ann Intern Med; 2017 Oct; 167(7):476-483. PubMed ID: 28973211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial.
    Hughes R; Dalakas MC; Merkies I; Latov N; Léger JM; Nobile-Orazio E; Sobue G; Genge A; Cornblath D; Merschhemke M; Ervin CM; Agoropoulou C; Hartung HP;
    Lancet Neurol; 2018 Aug; 17(8):689-698. PubMed ID: 30001923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Gordon PA; Winer JB; Hoogendijk JE; Choy EH
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD003643. PubMed ID: 22895935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin for hypogammaglobulinemia after lung transplantation: a randomized crossover trial.
    Lederer DJ; Philip N; Rybak D; Arcasoy SM; Kawut SM
    PLoS One; 2014; 9(8):e103908. PubMed ID: 25090414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC).
    Bus SRM; Zambreanu L; Abbas A; Rajabally YA; Hadden RDM; de Haan RJ; de Borgie CAJM; Lunn MP; van Schaik IN; Eftimov F;
    Trials; 2021 Feb; 22(1):155. PubMed ID: 33608058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
    Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S
    J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with add-on IVIg in Myositis Early In the diSease course May be sUperior to Steroids alone for reaching CLinical improvEment (TIME IS MUSCLE): study protocol of a phase-2 double-blind placebo-controlled randomised trial.
    Kamperman RG; Bogaards JA; Evers SW; Walter HAW; de Visser M; de Borgie C; Colen-de Koning JCA; Verhamme C; Maas M; Eftimov F; van Schaik IN; van der Kooi AJ; Raaphorst J
    BMJ Open; 2023 Jul; 13(7):e067435. PubMed ID: 37429682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
    Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial.
    Miyasaka N; Hara M; Koike T; Saito E; Yamada M; Tanaka Y;
    Mod Rheumatol; 2012 Jun; 22(3):382-93. PubMed ID: 21971943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial.
    Mazeraud A; Jamme M; Mancusi RL; Latroche C; Megarbane B; Siami S; Zarka J; Moneger G; Santoli F; Argaud L; Chillet P; Muller G; Bruel C; Asfar P; Beloncle F; Reignier J; Vinsonneau C; Schimpf C; Amour J; Goulenok C; Lemaitre C; Rohaut B; Mateu P; De Rudnicki S; Mourvillier B; Declercq PL; Schwebel C; Stoclin A; Garnier M; Madeux B; Gaudry S; Bailly K; Lamer C; Aegerter P; Rieu C; Sylla K; Lucas B; Sharshar T
    Lancet Respir Med; 2022 Feb; 10(2):158-166. PubMed ID: 34774185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels.
    Göttfried I; Seeber A; Anegg B; Rieger A; Stingl G; Volc-Platzer B
    Eur J Dermatol; 2000; 10(1):29-35. PubMed ID: 10694294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
    Illa I
    J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.